4.3 Article

Including all individuals is not enough: Lessons for intention-to-treat analysis

期刊

CLINICAL TRIALS
卷 9, 期 4, 页码 396-407

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/1740774512450098

关键词

-

资金

  1. Medical Research Council Unit [U105260558]
  2. ESRC Research Fellowship [RES-063-27-0257]
  3. NIH [5R01MH054693-11]
  4. Medical Research Council [MC_U105260558] Funding Source: researchfish
  5. MRC [MC_U105260558] Funding Source: UKRI

向作者/读者索取更多资源

Background Intention-to-treat (ITT) analysis requires all randomised individuals to be included in the analysis in the groups to which they were randomised. However, there is confusion about how ITT analysis should be performed in the presence of missing outcome data. Purposes To explain, justify, and illustrate an ITT analysis strategy for randomised trials with incomplete outcome data. Methods We consider several methods of analysis and compare their underlying assumptions, plausibility, and numbers of individuals included. We illustrate the ITT analysis strategy using data from the UK700 trial in the management of severe mental illness. Results Depending on the assumptions made about the missing data, some methods of analysis that include all randomised individuals may be less valid than methods that do not include all randomised individuals. Furthermore, some methods of analysis that include all randomised individuals are essentially equivalent to methods that do not include all randomised individuals. Limitations This work assumes that the aim of analysis is to obtain an accurate estimate of the difference in outcome between randomised groups and not to obtain a conservative estimate with bias against the experimental intervention. Conclusions Clinical trials should employ an ITT analysis strategy, comprising a design that attempts to follow up all randomised individuals, a main analysis that is valid under a stated plausible assumption about the missing data, and sensitivity analyses that include all randomised individuals in order to explore the impact of departures from the assumption underlying the main analysis. Following this strategy recognises the extra uncertainty arising from missing outcomes and increases the incentive for researchers to minimise the extent of missing data. Clinical Trials 2012; 9: 396-407. http://ctj.sagepub.com

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据